Home > Insider Trading > Filing (0001209191-14-063274)

Filing Details

Accession Number:: 0001209191-14-063274
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-10-15 13:58:55
Reporting Period:: 2014-10-13

Filing Date:: 2014-10-15
Accepted Time:: 2014-10-15 13:58:55
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1415336	Zeltiq Aesthetics Inc	ZLTQ	Electromedical & Electrotherapeutic Apparatus (3845)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1529196	J Mark Foley	4698 Willow Road Suite 100 Pleasanton CA 94588	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2014-10-13	29,869	$21.29	616,822	No	4	F	Direct
Common Stock	Disposition	2014-10-13	4,666	$21.29	612,156	No	4	F	Direct
Common Stock	Disposition	2014-10-14	6,319	$21.56	605,837	No	4	S	Direct
Common Stock	Disposition	2014-10-14	804	$21.96	605,033	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Represents the number of shares withheld by and surrendered to the Issuer on October 13, 2014, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU grant on August 23, 2012 of 286,215 shares. The initial grant vests in five equal installments, each on the first date that the weighted average stock price of ZELTIQ Common Stock during the immediately preceding 90-day period is $10 or more, $15 or more, $20 or more, $25 or more, and $30 and more, respectively.
Represents the number of shares withheld by and surrendered to the Issuer on October 13, 2014, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU granted on August 23, 2012 for 429,333 shares. The RSU vested with respect to 25% of the underlying shares on October 13, 2013 and the remaining shares shall vest monthly thereafter in 36 equal installments.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 17, 2014.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.91 to $21.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.93 to $22.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.